BD recently issued a medical device correction later related to its Bard subsidiary’s Rotarex atherectomy system. The company identified a number of anatomical factors that could contribute to catheter helix fracture and/or breakage. It reports 30 serious injuries and four deaths associated with the issue. Additionally, BD reported 115 cases requiring additional intervention following helix […]
Bard
AngioDynamics settles patent litigations with BD’s Bard
AngioDynamics entered into a settlement agreement with BD to resolve all patent litigations with Bard. Under terms of the agreement, BD will grant a license to AngioDynamics under certain of BD’s port patents. AngioDynamics will grant BD a license under certain of AngioDynamics’ catheter payments. AngioDynamics will also make a one-time payment of $7 million, […]
